Myelodysplastic syndromes trials in Taiwan
6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Changhua, Taichung, Tainan, Taipei, Taoyuan City
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - Phase 3Taking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Changhua, Kaohsiung City, Taichung, Tainan, Taipei
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Kaohsiung City, Taichung, Tainan, Taipei
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - No phaseTaking peopleAsia Myelodysplastic Syndrome (MDS) Registry
- Where
- Taipei
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07355478 - Phase 3Taking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Kaohsiung, San Ming Dist., Taichung, Taipei
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555